GlaxoSmithKline Meningococcus Vaccine Patent Application US20260097107A1
Summary
The USPTO published patent application US20260097107A1 for GlaxoSmithKline Biologicals SA covering meningococcal vaccines containing multiple alleles or variants of the fHbp protein to broaden coverage. The application was filed on October 29, 2025, and names inventors Alessia BIOLCHI, Brunella BRUNELLI, Marzia Monica GIULIANI, and Vega MASIGNANI.
What changed
The USPTO published a patent application (US20260097107A1) filed by GlaxoSmithKline Biologicals SA for meningococcal vaccines incorporating multiple alleles or variants of Factor H binding protein (fHbp) to provide broader coverage against diverse meningococcal strains and/or reduce OMV component quantity per dose.
Competitors developing meningococcal vaccines should monitor this patent's claims for freedom-to-operate considerations. Other pharmaceutical companies may seek licensing arrangements if the technology proves commercially valuable. This patent publication does not create immediate compliance obligations but establishes intellectual property rights that may affect future vaccine development strategies.
What to do next
- Monitor patent claims for freedom-to-operate analysis
- Review patent scope for competitive product development implications
- Contact GSK licensing department if seeking patent access
Archived snapshot
Apr 11, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
MENINGOCOCCUS VACCINES
Application US20260097107A1 Kind: A1 Apr 09, 2026
Assignee
GLAXOSMITHKLINE BIOLOGICALS SA
Inventors
Alessia BIOLCHI, Brunella BRUNELLI, Marzia Monica GIULIANI, Vega MASIGNANI
Abstract
Meningococcal vaccines can be improved by including multiple alleles or variants of fHbp, in order to provide broader coverage of the diversity which is known for this protein, and/or by reducing the quantity of an OMV component in each dose.
CPC Classifications
A61K 39/095 A61K 39/00 A61K 39/116 C07K 14/22 A61K 2039/70 C07K 2319/00
Filing Date
2025-10-29
Application No.
19372898
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.